UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 3045: Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary tumor cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3045-3045

2012

Volltextzugriff (PDF)

Abstract 4629: Physiologically based pharmacokinetic model and correlative in vitro assessment of metabolism-based interaction between Everolimus and PI3K/mTOR inhibitor BEZ235

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4629-4629

2014

Volltextzugriff (PDF)

Achieving big with small: quantitative clinical pharmacology tools for drug development in pediatric rare diseases

Journal of pharmacokinetics and pharmacodynamics, 2023-12, Vol.50 (6), p.429-444

2023

Volltextzugriff (PDF)

Application of Clinical Pharmacology Principles in Drug Development of Modified‐Release Products: Leveraging Exposure‐Response Information to Support Approval

Journal of clinical pharmacology, 2020-11, Vol.60 (11), p.1441-1452

2020

Volltextzugriff (PDF)

Clinical Drug Development for Rare Disease in Neurology (P2.194)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins

Clinical pharmacology and therapeutics, 2024-03, Vol.115 (3), p.440-451

2024

Volltextzugriff (PDF)

Clinical Pharmacology in Drug Development for Rare Diseases in Neurology: Contributions and Opportunities

Clinical pharmacology and therapeutics, 2022-04, Vol.111 (4), p.786-798

2022

Volltextzugriff (PDF)

Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: in vitro, in situ and in vivo studies

Biopharmaceutics & drug disposition, 2012-07, Vol.33 (5), p.246-256

2012

Volltextzugriff (PDF)

Development and validation of a reversed-phase HPLC method for the determination of γ-tocotrienol in rat and human plasma

Biomedical chromatography, 2011-05, Vol.25 (5), p.621-627

2011

Volltextzugriff (PDF)

Differences in amyloid-β clearance across mouse and human blood–brain barrier models: Kinetic analysis and mechanistic modeling

Neuropharmacology, 2014-04, Vol.79, p.668-678

2014

Volltextzugriff (PDF)

Digital technologies: Innovations that transform the face of drug development

Clinical and translational science, 2023-08, Vol.16 (8), p.1323-1330

2023

Volltextzugriff (PDF)

Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats

Planta medica, 2011-11, Vol.77 (17), p.1883-1889

2011

Volltextzugriff (PDF)

Enhancement of Intestinal Permeability Utilizing Solid Lipid Nanoparticles Increases [gamma]-Tocotrienol Oral Bioavailability

Lipids, 2012-05, Vol.47 (5), p.461

2012

Volltextzugriff (PDF)

Enhancement of Intestinal Permeability Utilizing Solid Lipid Nanoparticles Increases γ-Tocotrienol Oral Bioavailability

Lipids, 2012-05, Vol.47 (5), p.461-469

2012

Volltextzugriff (PDF)

Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision

Clinical pharmacology and therapeutics, 2023-09, Vol.114 (3), p.507-510

2023

Volltextzugriff (PDF)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers

Clinical pharmacology and therapeutics, 2024-08

2024

Volltextzugriff (PDF)

Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies

Drug metabolism and disposition, 2010-06, Vol.38 (6), p.939-945

2010

Volltextzugriff (PDF)

Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors

Bioorganic & medicinal chemistry, 2010-11, Vol.18 (22), p.8066-8075

2010

Volltextzugriff (PDF)

Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines

Fitoterapia, 2013-01, Vol.84, p.347-359

2013

Volltextzugriff (PDF)

Sesamin synergistically potentiates the anticancer effects of I3-tocotrienol in mammary cancer cell lines

Fitoterapia, 2013-01, Vol.84, p.347-359

2013

Volltextzugriff (PDF)

In Silico Modeling for the Nonlinear Absorption Kinetics of UK-343,664: A P-gp and CYP3A4 Substrate

Molecular pharmaceutics, 2012-03, Vol.9 (3), p.492-504

2012

Volltextzugriff (PDF)

Transporters as Drug Targets in Neurological Diseases

Clinical pharmacology and therapeutics, 2016-11, Vol.100 (5), p.441-453

2016

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Abstract 3045: Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary tumor cells

Abstract 4629: Physiologically based pharmacokinetic model and correlative in vitro assessment of metabolism-based interaction between Everolimus and PI3K/mTOR inhibitor BEZ235

Achieving big with small: quantitative clinical pharmacology tools for drug development in pediatric rare diseases

Application of Clinical Pharmacology Principles in Drug Development of Modified‐Release Products: Leveraging Exposure‐Response Information to Support Approval

Clinical Drug Development for Rare Disease in Neurology (P2.194)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins

Clinical Pharmacology in Drug Development for Rare Diseases in Neurology: Contributions and Opportunities

Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: in vitro, in situ and in vivo studies

Development and validation of a reversed-phase HPLC method for the determination of γ-tocotrienol in rat and human plasma

Differences in amyloid-β clearance across mouse and human blood–brain barrier models: Kinetic analysis and mechanistic modeling

Digital technologies: Innovations that transform the face of drug development

Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats

Enhancement of Intestinal Permeability Utilizing Solid Lipid Nanoparticles Increases [gamma]-Tocotrienol Oral Bioavailability

Enhancement of Intestinal Permeability Utilizing Solid Lipid Nanoparticles Increases γ-Tocotrienol Oral Bioavailability

Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers

Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies

Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors

Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines

Sesamin synergistically potentiates the anticancer effects of I3-tocotrienol in mammary cancer cell lines

In Silico Modeling for the Nonlinear Absorption Kinetics of UK-343,664: A P-gp and CYP3A4 Substrate

Transporters as Drug Targets in Neurological Diseases

Suchergebnisse filtern